Dr. Dietmar Aichhorn

Dr. Dietmar Aichhorn currently serves as the Chief Operating Officer at Hyloris Pharmaceuticals, a position held since October 2020. Prior to this role, Dr. Aichhorn contributed to Polpharma Biologics in clinical development and sponsor oversight from May 2017 to October 2020, and led clinical development at ViraTherapeutics, where responsibilities included creating clinical development plans and risk management strategies. Additionally, Dr. Aichhorn held the position of Head of Development & Pharmacovigilance at Innovacell Biotechnologie AG, focusing on tissue engineering and muscle cell therapy from April 2011 to June 2016. The professional background also includes significant experience at Mylan Labs, Sandoz Pharmaceuticals, and CATT innovation management GmbH, with expertise in project management and integration activities. Dr. Aichhorn's educational credentials include a Doctorate in Strategic Management from WU Vienna and advanced Project Management studies from The George Washington University, alongside a degree in Chemistry and Economics from Johannes Kepler University Linz.